Shares of 2seventy bio, Inc. (NASDAQ:TSVT – Get Free Report) have received a consensus rating of “Hold” from the eight ...

Equities research analysts at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Genmab A/S ...

Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Align Tech (ALGN – Research Report) today and set a price target of $275.00.

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

Adds Regeneron comment Regeneron Pharmaceuticals (NASDAQ:REGN) dropped 1.6% after the company's loss against Amgen ...